Skip to content

enVista Aspire™ Toric IOL ETA (REF ETAU350+180)Recalls & reported problems

Bausch & Lomb Incorporated · enVista Aspire toric hydrophobic acrylic IOL (non-preloaded) +18.00D SE / +3.50D CYL · Class 3 · Implant

All models of enVista Aspire Toric IOL (513)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
1

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10757770624529), received between Apr 9, 2025 and Apr 9, 2025 — classified as 1 injury.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Mar 27, 2025Class IOpen, Classified

    In response to an increased number of reports of toxic anterior segment syndrome (TASS) in conjunction with implantation of enVista Aspire and enVista Envy IOLs, and certain enVista monofocal lenses in the U.S.

    Z-1679-2025 · Root cause: Process control · Recall details · FDA record ↗

Most reported problems

Device problems

  • Insufficient Device Problem Information1

Patient problems

  • Blurred Vision1
  • Corneal Edema1
  • Endophthalmitis1
  • Eye Pain1
  • Hypopyon1
  • Intraocular Pressure Increased1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 9, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    IT WAS REPORTED THAT ONE WEEK POST-IMPLANTATION (IOL) INTO THE RIGHT EYE, THE PATIENT EXPERIENCED DECREASED VISUAL ACUITY. A SLIT LAMP EXAMINATION SHOWED 3-4 CORNEAL EDEMA WITH THE PRESENCE OF HYPOPYON, BCDVA VISUAL ACUITY (VA) MEASUREMENTS WAS LIGHT PERCEPTION. THE PATIENT WAS REFERRED TO A RETINAL SPECIALIST. FOLLOW UP ONE WEEK POST-OP WITH A RETINAL SPECIALIST SHOWED SLIT LAMP EXAM INDICATES 2+ DESCEMET'S FOLDS, 4+ CELL, LESS THAN 1MM LAYERED HYPOPYON AND FIBRIN RETRACTING OVER PUPIL AND FIBRINOUS INFLAMMATION. THE PATIENT WAS DIAGNOSED WITH ENDOPHTHALMITIS IN THE RIGHT EYE. PATIENT WAS INJECTED WITH AN URGENT VITREOUS TAP OF VANCOMYCIN/CEFTAZIDIME. AFTER THE INJECTION THE PATIENTS VITREOUS TAP THE PATIENTS IOP SPIKED TO 84 MMHG. AN ANTERIOR CHAMBER TAP WAS PERFORMED AND THE IOP RETURNED TO 17 MMHG. THE PATIENT WAS INSTRUCTED TO START PRED ACETATE 1% EVERY HOUR AND ATROPINE TWICE A DAY. A B-SCAN WAS PERFORMED AND DUE TO DESCEMETS FOLDS AND HYPOPYON THERE WAS NO VIEW TO THE POSTERIOR POLE. PATIENT WAS INSTRUCTED TO USE TOPICAL PREDNISOLONE ACETATE 1% Q1H AND ATROPINE TWICE A DAY. THE FOLLOWING DAY THE PATIENT RETURNED TO THE RETINAL SPECIALIST. PATIENTS VA UVDVA WAS STABLE AT HAN

    Patient problems: Blurred Vision; Corneal Edema; Endophthalmitis; Eye Pain; Hypopyon; Intraocular Pressure Increased

    MAUDE report 21810212 ↗

Other Intraocular Lens devices

All Intraocular Lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page